2ϩ -permeable AMPA receptors may play a key role during developmental neuroplasticity, learning and memory, and neuronal loss in a number of neuropathologies. However, the intracellular signaling pathways used by AMPA receptors during such processes are not fully understood. The mitogenactivated protein kinase (MAPK) cascade is an attractive target because it has been shown to be involved in gene expression, synaptic plasticity, and neuronal stress. Using primary cultures of mouse striatal neurons and a phosphospecific MAPK antibody we addressed whether AMPA receptors can activate the MAPK cascade. We found that in the presence of cyclothiazide, AMPA caused a robust and direct (no involvement of NMDA receptors or L-type voltage-sensitive Ca 2ϩ channels) Ca 2ϩ -dependent activation of MAPK through MAPK kinase (MEK). This activation was blocked by GYKI 53655, a noncompetitive selective antagonist of AMPA receptors. Probing the mechanism of this activation revealed an essential role for phosphatidylinositol 3-kinase (PI 3-kinase) and the involvement of a pertussis toxin (PTX)-sensitive G-protein, a Src family protein tyrosine kinase, and Ca 2ϩ /calmodulin-dependent kinase II. Similarly, kainate activated MAPK in a PI 3-kinase-dependent manner. AMPA receptor-evoked neuronal death and arachidonic acid mobilization did not appear to involve signaling through the MAPK pathway. However, AMPA receptor stimulation led to a Ca 2ϩ -dependent phosphorylation of the nuclear transcription factor CREB, which could be prevented by inhibitors of MEK or PI 3-kinase. Our results indicate that Ca 2ϩ -permeable AMPA receptors transduce signals from the cell surface to the nucleus of neurons through a PI 3-kinasedependent activation of MAPK. This novel pathway may play a pivotal role in regulating synaptic plasticity in the striatum.
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Key words: AMPA; mitogen-activated protein kinase; phosphatidylinositol 3-kinase; CREB; wortmannin; LY 294002; pertussis toxin; G-protein; PP2; cyclothiazide; glutamate; kainate; calcium/calmodulin-dependent kinase II; tyrosine kinase; AMPA toxicity; arachidonic acid; striatum; striatal neurons Glutamate is the major excitatory neurotransmitter in the mammalian C NS and acts through two classes of receptor: NMDA and non-NMDA [AM PA and kainate (K A)] ionotropic receptors, and G-protein-coupled metabotropic receptors (Hollmann and Heinemann, 1994; Ozawa et al., 1998) . Ionotropic glutamate receptors mediate a wide range of physiological processes such as fast excitatory synaptic transmission and neuronal plasticity (Mayer and Westbrook, 1987; Monaghan et al., 1989; Lerma et al., 1997; Ozawa et al., 1998) , and their overactivation has been implicated in excitotoxic neuronal loss that occurs during a number of neuropathological conditions (Choi, 1992; PellegriniGiampietro et al., 1997; Michaelis, 1998 ). It appears that extracellular C a 2ϩ influx through glutamate receptor ion channels plays a central role in gene expression associated with synaptic plasticity (Deisseroth et al., 1996; Finkbeiner and Greenberg, 1996; X ia et al., 1996) , neuronal development, and survival (Bading et al., , 1995 Ikonomidou et al., 1999) and activitydependent synaptogenesis (Constantine-Paton and C line, 1998; Lin and Constantine-Paton, 1998) . There is accumulating evidence suggesting that these processes may require the transduction of signals through the mitogen-activated protein kinase [(MAPK) ERK1 and ERK2] cascade, which classically involves Shc tyrosine phosphorylation, recruitment of the Grb2-Sos complex, and the subsequent sequential activation of Ras, Raf kinase, and MAPK kinase (MEK) (Rosen et al., 1994; Fukunaga and Miyamoto, 1998) . NMDA receptor-induced immediate early gene transcription and induction of hippocampal long-term potentiation (LTP) are both thought to involve a Ca 2ϩ -dependent activation of the Ras-MAPK pathway in neurons (English and Sweatt, 1996; Finkbeiner and Greenberg, 1996; Xia et al., 1996; English and Sweatt, 1997) , however, studies regarding AMPA receptor activation of this cascade are somewhat contradictory. Although AMPA and kainate do not appear to activate MAPK in hippocampal neurons (Kurino et al., 1995) , it has been reported that AMPA receptors can stimulate MAPK in cortical neurons through a mechanism that surprisingly requires G-protein ␤␥ subunits (Wang and Durkin, 1995) , which is classically associated with receptors that couple to heterotrimeric G-proteins (Crespo et al., 1994; Luttrell et al., 1997; Gutkind, 1998) . Recent studies have shown that phosphatidylinositol 3-kinase (PI 3-kinase) plays a crucial role in ␤␥ signaling to MAPK at a target upstream of Sos and Ras (Hawes et al., 1996 ; Lopez-Ilasaca et al., 1997), although For NMDA agonist treatments and C a 2ϩ dependency studies, MgC l 2 and CaCl 2 were omitted from the HBM, respectively. Other additions before agonist /depolarization treatments were made as detailed in the legends to the Figures. After 10 min of incubation, fresh HBM containing AM PA (50 M) (in the presence or absence of 50 M cyclothiazide), glutamate (100 M), kainate (100 M), NMDA (100 M), (1S,3R)-AC PD (200 M), KC l (50 mM), or ionomycin (5 M) was added to the neurons. After 5 min, the HBM was removed, and the plates were quickly washed with ice-cold PBS, pH 7.4, (C a 2ϩ -free) and placed immediately on ice. The cell monolayer was rapidly scraped in ice-cold lysis buffer (200 l / well) [50 mM Tris, pH 7.5, 150 mM NaC l, 1% Tergitol (type N P-40), 2 mM EDTA, 2 mM EGTA, 0.5 mM PMSF, 10 g /ml leupeptin, 10 g /ml antipain, 1 g /ml pepstatin A, 1 mM Na 3 V0 4 , and 50 mM NaF], left on ice for 10 min, then homogenized with 20 f ull strokes in a glass-on-glass hand-held homogenizer and centrif uged at 1000 ϫ g for 4 min at 4°C to remove cell debris. The supernatant (crude homogenate) was kept, and protein concentration was determined by the assay of Bradford (1976) . Samples were then boiled for 5 min in boiling buffer, giving 62.5 mM Tris, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, and 0.0025% bromophenol blue in the final sample. Boiled samples (15 g / lane) were run on 7.5% SDS-polyacrylamide gels, and proteins were transferred to nitrocellulose membrane (Hybond-C pure; Amersham) by electroblotting. The equal loading and efficient transfer of proteins was confirmed by staining the nitrocellulose with Ponceau Red (Sigma). The nitrocellulose membrane was then incubated in blocking buffer (20 mM Tris, pH 7.5, 150 mM NaC l; TBS) containing 5% skimmed milk powder, for 30 min at room temperature on a three-dimensional rocker, followed by two 10 min washes in TBS supplemented with 0.1% (v/ v) T ween 20 (TTBS). Blots were then incubated with anti-AC TIV E M APK pAb (1:12,500 dilution of stock), anti-ERK1/ ERK2 pAb (1:750 dilution of stock), or anti-phospho-Ser 133 CREB pAb (1:1500 dilution of stock) in TTBS containing 1% skimmed milk powder (antibody buffer), overnight at room temperature on a three-dimensional rocker. The blots were washed (2 ϫ 10 min) in TTBS and then incubated with goat anti-rabbit IgG conjugated to horseradish peroxidase (1:1000 dilution of stock) in antibody buffer for 1 hr. Finally, the blots were washed in TTBS (2 ϫ 10 min), rinsed in TBS, and exposed to ECL reagent for 1 min, as described in the Amersham protocol. E xcess reagent was removed, and the blots were then exposed to Hyperfilm ECL (Amersham) for 2 min in an autoradiographic cassette and developed. Bands were analyzed using BioImage Intelligent Quantifier software (Ann Arbor, M I) Molecular weights of ERK1/ ERK2 and CREB were calculated from comparison with prestained molecular weight markers (MW 27,000 -180,000) that were run in parallel with samples.
Immunoc ytochemistr y. For immunocytochemical studies, neurons were cultured in 24-well plates and incubated in HBM, pH 7.4, at 37°C, as described for immunoblot analysis. In experiments involving AM PA receptor stimulation, (ϩ)-M K 801 (2 M) was present in the HBM to block NMDA-type glutamate receptors. Other additions before agonist treatment were made as detailed in the legends to Figures 9 and 10 B. After 10 min of incubation, fresh HBM containing AM PA (50 M) (in the presence of 50 M cyclothiazide) was added to the neurons. After a f urther 5 min, the HBM was removed, and the plates were quickly rinsed with ice-cold PBS, pH 7.4, (C a 2ϩ -free), and neurons were fixed on ice in PBS containing 4% paraformaldehyde for 1 hr. All other procedures were performed at room temperature. Neurons were permeabilized with 0.2% Triton X-100 made up in PBS containing 1% goat serum (blocking solution) for 1 hr and then incubated with anti-AC TIV E M APK pAb (1:500 dilution of stock), ERK1/ ERK2 pAb (1:200 dilution of stock), or anti-phospho-Ser 133 CREB pAb (1:500 dilution of stock) overnight with constant agitation. After 3 ϫ 10 min washes in PBS, neurons were incubated with biotinylated goat antibody to rabbit IgG (1:200 dilution of stock) for 1 hr, washed 3 ϫ 10 min with PBS, and neuronal staining was localized using the avidin -biotin -peroxidase detection system (Vector Laboratories). Neurons were visualized using a Leica Fluovert microscope.
Intracellular Ca 2ϩ measurements. Striatal neurons prepared as described above, were plated into 24-well Nunc multiwell plates containing 13 mm diameter glass coverslips that had been previously coated overnight with 15 g /ml poly-L-ornithine and then with 2 g /ml laminin (Life Technologies) for 4 hr. After 6 -7 DIV, neurons were loaded with the cell-permeant fluorescent C a 2ϩ -probe f ura-2 AM (5 M) in HBM, pH 7.4, for 45 min at 37°C. Subsequent procedures were performed at room temperature (20 -25°C). Coverslips with f ura-2-loaded neurons were clamped to a purpose-made recording chamber attached to a Nikon Diaphot 200 inverted microscope stage and preincubated in HBM, pH 7.4, with or without inhibitors, as detailed in the legend to Table 1 . Neurons were stimulated with AM PA (50 M) or AM PA /cyclothiazide (50 M/50 M), and to ensure that AM PA receptor-mediated changes in intracellular C a 2ϩ were being observed in the absence of possible NMDA receptor responses, 1 mM MgC l 2 and 2 M (ϩ)-M K 801 were included in the HBM. Neurons were alternately excited at 340 and 380 nm using a C airn filter changer. Fluorescence at each excitation wavelength was filtered using a 420 nm barrier filter/400 nm dichroic mirror set and collected using a C4880 -81Hamamatsu multiformat CCD camera (Hamamatsu Photonics K .K ., Hamamatsu C ity, Japan). Data acquisition and analysis was performed using Acquisition Manager (version 3.1) and L ucida Analyze (version 3.51) software from K inetic Imaging (Liverpool, UK). To improve the signal-to-noise ratio, the collection period during 340 nm excitation (600 msec) was set at three times that used at 380 nm (200 msec) . Ratio values in the data presented have not been corrected for this difference. Fluorescence responses from at least six cells in a single field were analyzed on each coverslip. For each experimental condition, cells were analyzed on a minimum of three coverslips from at least two separate striatal cultures. Means Ϯ SEM of the 340 nm /380 nm ratio traces are reported in Figure 3 , and means Ϯ SEM of the agonist-induced increases in the ratio values evaluated in Table 1 .
Arachidonic acid release. Arachidonic acid release was performed essentially as described previously (Samanta et al., 1998) . Neurons, cultured in 24-well plates were incubated overnight with 0.5 C i /ml [ 3 H]arachidonic acid. Unincorporated label was removed by three successive washes in HBM, pH 7.4, containing fatty acid-free BSA (2 mg /ml; HBM / BSA), and neurons were then preincubated for 10 min in HBM / BSA at 37°C in the presence or absence of enzyme inhibitors, with or without cyclothiazide (50 M). After removal of the preincubation buffer, neurons were incubated for 15 min in HBM / BSA containing either vehicle or AM PA /cyclothiazide (50 M/50 M), at 37°C in the continued presence or absence of enzyme inhibitors, as detailed in the legend to Figure 7 . The extracellular medium was removed and centrif uged at 400 ϫ g for 5 min to remove dislodged cells and the radioactivity in the supernatant was measured by scintillation counting. Because arachidonic acid is poorly metabolized in primary cultured mouse neurons (Oomagari et al., 1991) , the 3 H released was assumed to be essentially [ 3 H]arachidonic acid.
Neuronal viabilit y. E xperiments were performed using neurons cultured in 24-well plates. The effect of AM PA on neuronal viability was assessed by a colorimetric assay based on the cleavage of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) into a blue-colored formazan product by mitochondrial succinate dehydrogenase. Additions and agonist treatments were made directly to the neuronal culture medium for 4 hr, as detailed in the legend to Figure 8 . Neurons were then washed twice with HBM, pH 7.4, and incubated for 45 min at 37°C in HBM containing MTT (0.5 mg /ml). After this period, the HBM was caref ully removed, and the blue formazan product was solubilized in 300 l of 100% dimethyl sulfoxide. The absorbance of each well was read at 570 nm. Morphological assessment of the effect of AM PA on neuronal viability was made by phase contrast microscopy as detailed in the legend to Figure 8 .
Data handling. Immunoblot band intensity, [ 3 H]arachidonic acid release, neurotoxicity, and intracellular C a 2ϩ data were analyzed by unpaired two-tailed Student's t tests. Differences were considered to be of statistical significance when p Ͻ 0.05.
RESULTS
The non-NMDA glutamate receptor desensitization inhibitor cyclothiazide unmasks an AMPA-induced activation of MAPK in cultured striatal neurons
The glutamate receptor agonist AM PA can evoke a range of physiological and neurotoxic processes in striatal neurons (Lovinger and T yler, 1996; Williams and Glowinski, 1996; C alabresi et al., 1998 ) by binding to a heterogenous population of postsynaptic AMPA-type glutamate receptors assembled from different combinations of GluR1-GluR4 subunits (Bernard et al., 1997; Kwok et al., 1997 ). The precise nature of the intracellular mechanisms activated subsequent to AM PA receptor stimulation are not fully understood. Recently, much attention has been focused on the possible physiological and pathological roles that the MAPK cascade may play at glutamatergic synapses (Fukunaga and Miyamoto, 1998; Murray et al., 1998; Sgambato et al., 1998) . Indeed, it has been demonstrated in many neuronal types, including striatal neurons, that stimulation of NMDA-type glutamate receptors causes a Ca 2ϩ -dependent activation of MAPK (Xia et al., 1996; Vincent et al., 1998) . Although postsynaptic AMPA receptors are classically associated with low Ca 2ϩ permeability (Hollmann and Heinemann, 1994 ) Ca 2ϩ -permeable AMPA receptors are present in the striatum (Williams and Glowinski, 1996) and, thus, there may be a population of striatal AMPA receptors that can couple to MAPK in a Ca 2ϩ -dependent manner. However, a direct coupling of Ca 2ϩ -permeable AMPA receptors to MAPK has not been shown in striatal neurons.
To test whether stimulation of striatal AMPA receptors leads to activation of the ERK1/ERK2 forms of MAPK, immunoblotting of neuronal homogenates with an anti-ACTIVE MAPK pAb, which recognizes the dually phosphorylated Thr/Glu/Tyr region within the catalytic core of the active form of ERK1 (p44) and ERK2 (p42) was performed. Treatment of striatal neurons with AMPA (50 M) for 5 min failed to activate MAPK ( Fig. 1 A, lane 3) because there was no significant increase in immunodetectable activated ERK1 and ERK2 (seen as two bands of ϳ44 and 42 kDa, respectively) above basal levels ( Fig. 1 A, lane 1) . However, we have previously shown that in cultured striatal neurons, AMPA receptor-mediated responses are rapidly desensitizing (Williams and Glowinski, 1996) . To establish whether an apparent lack of activation of MAPK by AMPA in these neurons is caused by rapid AMPA receptor desensitization, striatal neurons were preincubated with the AMPA receptor-specific desensitization inhibitor cyclothiazide (50 M). In the presence of cyclothiazide, AMPA evoked a large increase in the intensity of the two immunodetectable bands (44 and 42 kDa) compared with basal levels, corresponding to the activated forms of MAPK, ERK1 and ERK2 ( Fig. 1 A, lane 4, B) . Cyclothiazide alone did not activate ERK1 or ERK2 ( Fig. 1 A, lane 2), indicating that it was acting specifically at AMPA receptors and was not directly activating MAPK. A set of parallel immunoblots with an antibody that detects total MAPK (active and inactive ERK1/ERK2) were performed to show that the total levels of MAPK were not altered by any of the drug treatments ( Fig. 1 A, lanes 5-8) . Complementing our results with the anti-ACTIVE MAPK pAb, AMPA/ cyclothiazide treatment revealed a doublet of 42 kDa immunoreactivity (seen as a faint slower-migrating band just above the main 42 kDa band) ( Fig. 1 A, lane 8) , indicative of an AMPA-mediated phosphorylation of p42 MAPK.
Activation of MAPK by AMPA/cyclothiazide could also be demonstrated at the single cell level. We first showed, by immunocytochemistry, the presence of the ERK1 and ERK2 forms of MAPK in striatal neurons (see Fig. 9Ai ). The majority of the neurons were immunopositive for MAPK, with the highest levels of staining found at the neuronal soma, and some weaker staining in the neurites. After closer examination of the cell body, a narrow outer ring of intense staining was visible in the majority of neurons (see Fig. 9Ai , white arrows), suggesting a cytosolic location for MAPK. Some nuclear staining was also detectable, but to a lesser extent. In a set of control experiments, omission of the primary antibody completely abolished staining for MAPK (see Fig. 9Aii ). Using the anti-ACTIVE MAPK pAb we showed that, under control conditions, basal levels of activated MAPK are very low (see Fig. 9Bi ), which may indicate that MAPK activation is tightly regulated in striatal neurons. However, single neurons containing activated M APK were visible after treatment of cultures with AM PA in the presence of cyclothiazide (see Fig. 9Bii , black arrow). When neurons were preincubated with the 2,3-benzodiazepine GYK I 53655 (100 M), a noncompetitive and selective antagonist of AM PA receptors, before application of AMPA /cyclothiazide, no staining for activated M APK could be detected (see Fig. 9Biii ). Thus, we have demonstrated, for the first time, an AM PA receptor-mediated activation of M APK (ERK1/ ERK2) in single isolated neurons.
Ca

2؉ influx through AMPA receptors triggers activation of MAPK in striatal neurons
Activation of the M APK cascade can be a C a 2ϩ -dependent process and in neurons, the activation of ERK1/ ERK2 by NMDA is completely dependent on the influx of C a 2ϩ through the receptor (Kurino et al., 1995; X ia et al., 1996) , thus, the possibility that our observed stimulation of M APK by AM PA receptors also (Fig. 2 A, lane 5) , AMPA/cyclothiazide (Fig. 2 A, lane 6 ) , and NMDA (data not shown)] failed to elicit an increase in the 44 kDa (ERK1) and 42 kDa (ERK2) band intensities above basal levels (in the absence of Ca 2ϩ ) (Fig. 2 A, lane  4 ) . Further evidence that extracellular Ca 2ϩ influx is a trigger for MAPK activation in striatal neurons came from the observation that the Ca 2ϩ ionophore ionomycin (5 M), which causes delocalized Ca 2ϩ entry after randomly intercalating at sites all over the neuronal plasma membrane, also activated MAPK [ (Fig. 2 B , lane 3 (ionomycin); lane 1 (basal)]. It is noticeable that ionomycin treatment did not appear to activate ERK1/ERK2 as efficiently as glutamate ( Fig. 2 B, lane 2) .
To confirm that AMPA/cyclothiazide-evoked MAPK activation resulted from the influx of Ca 2ϩ through AMPA receptors, intracellular Ca 2ϩ measurements were performed using fura-2-loaded neurons. AMPA caused a small rise in intracellular Ca 2ϩ , which was strongly potentiated (approximately threefold) in the presence of cyclothiazide (Fig. 3) . This response was completely blocked by preincubation with the selective AMPA receptor antagonist GYKI 53655 (100 M) (Fig. 3, Table 1 ).
AMPA receptor activation of MAPK occurs through MEK and is direct, with no involvement of NMDA receptors and/or L-type voltage-sensitive Ca 2؉ channels
We have shown at the single cell level that GYKI 53655, a selective antagonist at AMPA receptors can block AMPA/ cyclothiazide-induced MAPK activation (see Fig. 9B ). This finding was mirrored in large populations of cultured striatal neurons because the robust activation of ERK1/ERK2 by AMPA/cyclothiazide (Fig. 4 A, lane 3) was completely blocked by preincubation with GYKI 53655 (100 M) before AMPA/cyclothiazide treatment ( Fig. 4 A, lane 4, C). The direct upstream activator of MAPK is MAPK kinase (MEK) (Seger and Krebs, 1995) . To establish whether or not striatal AMPA receptors activate MAPK via the conventional pathway, i.e., phosphorylation of MAPK by MEK, we performed experiments with PD 98059, a specific inhibitor of the activation of MEK (Alessi et al., 1995) . Preincubation of neurons with PD 98059 (50 M) completely blocked AMPA/cyclothiazide-evoked activation of MAPK (ERK1/ERK2) (Fig. 4 A, 
lane 5, C).
Further pharmacological characterization of the AMPA receptor effect was performed to establish whether AMPA receptors are directly coupled to the MAPK cascade. Ca 2ϩ entry through NMDA receptors and/or L-type voltage-sensitive Ca 2ϩ channels (VSCC) can activate the MAPK pathway (Rosen et al., 1994; Xia et al., 1996) , thus, the ability of AMPA/cyclothiazide to activate MAPK in the presence of the NMDA receptor antagonist (ϩ)-MK 801 (2 M) or the L-type VSCC blocker nimodipine (5 M) was examined. The activation of MAPK by AMPA/cyclothiazide (Fig. 4 B, lane 2) was unaltered in the presence of either (ϩ)-MK 801 (Fig. 4 B, lane 4 ) or nimodipine (Fig. 4 B were immunoblotted with an antibody that specifically recognizes the dually phosphorylated Thr/Glu/Tyr region within the catalytic core of the active form of ERK1 and ERK2 (anti-AC TIV E M APK pAb) (lanes 1-4 ), or with an antibody that recognizes total levels of ERK1 and ERK2 (anti-ERK1/ERK2 pAb) (lanes 5-8). B, Data obtained from immunoblot experiments represented in lanes 1-4 was analyzed using BioImage Intelligent Quantifier software. Each column is the mean Ϯ SEM value of 6 -12 independent cultures (n ϭ 6 -12). **A MPA/Cyz was significantly different from control (Con) ( p Ͻ 0.001, unpaired two-tailed Student's t test).
receptors or L -type VSCC. Elevation of the external [K ϩ ] in the incubation buffer to 50 mM, which causes neuronal depolarization and influx of C a 2ϩ through VSCC, did not stimulate MAPK activity above basal levels (data not shown), thus, providing further evidence that L -type VSCC cannot be involved in AMPA receptor activation of M APK in cultured striatal neurons. Activation of neuronal MAPK may arise from the mobilization of intracellular Ca 2ϩ stores after stimulation of group I metabotropic glutamate receptors (mGluRs). However, the possibility that AMPA was acting as a ligand at group I mGluRs or that AMPA receptor stimulation was indirectly activating mGluRs was ruled out because, consistent with previous reports (Wang and Durkin, 1995; Vincent et al., 1998) It is known that MEK needs to be serine phosphorylated for its activation, and a likely kinase for performing this role is Raf (B-Raf or c-Raf-1) (Seger and Krebs, 1995) . Furthermore, in non-neuronal cells at least, it is known that Raf kinase is itself phosphorylated and consequently activated by one or more upstream kinases, with PKC and the protein tyrosine kinase (PTK) family being the most likely candidates (Seger and Krebs, 1995) . The involvement of PKC and/or protein tyrosine phosphorylation in AMPA receptor-evoked activation of MAPK in striatal neurons was tested using kinase inhibitors. Although NMDA receptor-induced activation of neuronal MAPK has been shown to be partially prevented by PKC inhibitors (Kurino et al., 1995; Vincent et al., 1998) Two families of nonreceptor PTKs, the Src family and the focal adhesion kinase (FAK) family, contain members that are prominently expressed in neurons (Boxall and Lancaster, 1998) 1, 2, 4 , 5) or presence (lanes 3, 6 ) of 50 M cyclothiazide (Cyz), and then exposed for 5 min to vehicle (lanes 1, 4 ) , 100 M glutamate (lanes 2, 5), or 50 M AMPA and 50 M Cyz (lanes 3, 6 ) in the presence (lanes 1-3) or absence (lanes 4-6 ) of CaCl 2 (1 mM), were immunoblotted with an antibody that specifically recognizes the dually phosphorylated Thr/Glu/Tyr region within the catalytic core of the active form of ERK1 and ERK2 (anti-ACTIVE MAPK pAb). In experiments in which C aC l 2 was omitted from the incubation medium, EGTA (200 M) was added 1 min before stimulation. B, Crude homogenates (15 g of each), prepared from striatal neurons exposed to vehicle (lane 1), 100 M glutamate (lane 2), or 5 M ionomycin (lane 3) for 5 min, were immunoblotted with anti-AC TIV E MAPK pAb. C, Data obtained from immunoblot experiments with AMPA/Cyz was analyzed using BioImage Intelligent Quantifier software. Each column is the mean Ϯ SEM value of six independent cultures (n ϭ 6). *AMPA/Cyz in the absence of C aC l 2 (A MPA/Cyz-Ca 2ϩ ) was significantly different from AM PA /C yz in the presence of C aC l 2 (A MPA/ Cyz) ( p Ͻ 0.05, unpaired two-tailed Student's t test). activation of the Ras/MAPK signaling pathway (Lev et al., 1995; Finkbeiner and Greenberg, 1996; Hayashi et al., 1999) , and it appears that protein tyrosine phosphorylation may be important at several points within the MAPK cascade. To test the involvement of tyrosine phosphorylation in AMPA receptor-evoked activation of MAPK, neurons were pretreated with the broad range tyrosine kinase inhibitor genistein (50 M) or the Src family-selective tyrosine kinase inhibitor PP2 (10 M) (Hanke et al., 1996) before AMPA/cyclothiazide. No activation of ERK1/ ERK2 by AMPA/cyclothiazide was detected in the presence of either genistein (Fig. 5A, lane 5, C) or PP2 [Fig. 5B , lane 3 vs lane 2 (AMPA/Cyz)], indicating that stimulation of a Src family protein tyrosine kinase activity is required for AMPA receptor coupling to MAPK. Preincubation of striatal neurons with the pyrazolo[3,4-d]pyrimidine, PP3 (10 M), a proposed negative control for PP2 (Traxler et al., 1997) , did cause some inhibition of AMPA receptor-evoked activation of ERK1/ERK2 (Fig. 5B, lane  4 ) , however, it was not as great as that caused by PP2. Ca 2ϩ /calmodulin-dependent kinase II (CaM-KII), a major protein present at the postsynaptic density region of neurons, is activated following increases in intracellular Ca 2ϩ (Hanson and Schulman, 1992) , thus, we considered that CaM-KII may play a role in our observed AMPA receptor activation of MAPK. Preincubation of striatal neurons with the selective CaM-KII inhibitor KN-62 (5 M) before AMPA/cyclothiazide caused a robust inhibition of AMPA receptor-evoked MAPK activation (Fig. 5A, lane 4, C) , indicating that CaM-KII may play an important regulatory role in the activation of MAPK by Ca 2ϩ -permeable AMPA receptors.
An essential role for a pertussis toxin-sensitive Gprotein and phosphatidylinositol 3-kinase (PI 3-kinase) in AMPA receptor coupling to MAPK
Application of AMPA to rat cerebral cortical neurons has been shown to lead to a rapid increase in Ras activity and activation of MAPK (Wang and Durkin, 1995) . Ras-dependent activation of MAPK is usually associated with seven transmembrane receptors that couple to heterotrimeric G-proteins (Gutkind, 1998) , however, it has been demonstrated in rat cortical neurons that AMPA activates ERK2 (p42) by causing a Ca 2ϩ -dependent association of G-protein ␤␥ subunits, probably G i , with a Ras, Raf kinase, MEK complex (Wang and Durkin, 1995; Wang et al., 1997) . This novel involvement of a heterotrimeric G-protein in ionotropic AMPA receptor signaling was examined. Striatal neurons were pretreated with pertussis toxin (PTX) (1 g/ml, made up in sterile PBS) or PBS vehicle for 24 hr before experiments with AMPA/cyclothiazide. In agreement with the results of Wang and Durkin (1995) , PTX treatment abolished AMPA receptor activation of MAPK [ Fig. 6 A, lane 3 vs lane 2 (AMPA/Cyz), C), indicating a role for a G i or G o -type G-protein in the activation of MAPK by AMPA receptors in striatal neurons.
More recently, additional links between G␤␥ subunits and the Ras-MAPK cascade have been identified. Wortmannin, a selective (low nanomolar range) inhibitor of PI 3-kinase has been reported to block G i -coupled receptor-induced MAPK activation (Hawes et al., 1996) , and experiments have indicated that PI 3-kinase is recruited by free G␤␥ subunits and coordinates the activation of Src-like nonreceptor PTKs involved in activating the Shc-Grb2-Sos complex (Lopez-Ilasaca et al., 1997; Gutkind, 1998) . Furthermore, it has been shown that PI 3-kinase activity can be regulated by Ca 2ϩ /calmodulin (Joyal et al., 1997) and therefore, the possibility that PI 3-kinase is required for AMPA receptor-mediated MAPK signaling was examined. Pretreatment of striatal neurons with wortmannin (100 nM) (Fig. 6 A, lane 4, C) or the highly selective PI 3-kinase inhibitor LY 294002 (50 M) (Fig. 6C ) completely blocked the activation of ERK1/ERK2 MAPK by AMPA/cyclothiazide. This is the first report that AMPA receptor coupling to MAPK is dependent on PI 3-kinase.
Complementing the AMPA/cyclothiazide data, in a set of additional experiments we showed that the nondesensitizing AMPA receptor agonist KA (100 M) also activated MAPK, exclusively through AMPA receptors (no involvement of kainate receptors was indicated by a complete sensitivity of the KA effect to GYKI 53655), in a PTX-and wortmannin-sensitive manner (Fig. 6 B) .
We considered it possible that the kinase inhibitors KN-62, PD 98059, genistein and wortmannin blocked AMPA/cyclothiazideevoked MAPK activation by inhibiting the entry of Ca 2ϩ through AMPA receptors. To address this, intracellular Ca 2ϩ measurements were made using fura-2-loaded neurons. AMPA/ cyclothiazide-evoked increases in cytosolic Ca 2ϩ were not altered by any of the kinase inhibitors tested (Table 1) , and, thus, it seems likely that CaM-KII, MEK, tyrosine kinase, and PI 3-kinase activities all have sites of action at points downstream of Ca 2ϩ influx.
Is cytosolic phospholipase A 2 (cPLA 2 ) a putative downstream target for ERK1/ERK2 MAP kinases in striatal neurons?
We have previously shown that stimulation of Ca 2ϩ -permeable cyclothiazide-sensitive AMPA receptors leads to a release of arachidonic acid (AA) from striatal neurons (Williams and Glowinski, 1996) . This release can be prevented by removing extracellular Ca 2ϩ or by preincubation with the selective cPLA 2 inhibitor AACOCF 3 before AMPA receptor stimulation (M. S. Perkinton and R. J. Williams, unpublished observations), suggesting that striatal AMPA receptors mobilize AA through the activation and Ca 2ϩ -dependent translocation of cPLA 2 . In non-neuronal cells, MAP kinases phosphorylate cPLA 2 on Ser 505 and/or Ser 727 , and it has been proposed that this may be crucial for agonist-induced activation of cPLA 2 (Lin et al., 1993; Borsch-Haubold et al., 1998) . Thus, it is possible that one of the functional consequences of AMPA receptor-mediated activation of MAPK in striatal neurons is the phosphorylation and activation of cPLA 2 leading to AA mobilization. To examine this possibility, AMPA receptorevoked [
3 H]AA release from striatal neurons was assayed in the absence or presence of inhibitors of MAPK activity. In control conditions, treatment of neurons with AMPA/cyclothiazide (50 M/50 M) produced a 175 Ϯ 8.5% release of [ 3 H]AA above basal levels (Fig. 7) . Preincubation of neurons with the MEK inhibitor PD 98059 (50 M) or the PI 3-kinase inhibitor wortmannin (100 nM), both of which completely inhibit AMPA receptor-evoked activation of the ERK1 and ERK2 forms of MAPK (Figs. 4 A, 6A , respectively), had no significant effect on AMPA receptor-evoked [ 3 H]AA release ( Fig. 7 ; AMPA/cyclothiazide ϩ wortmannin, 195 Ϯ 20% of paired basal; AMPA/cyclothiazide ϩ PD 98059, 196 Ϯ 6% of paired basal). These data strongly suggest that ERK1/ERK2 do not regulate agonist-evoked AA mobilization in cultured striatal neurons, although it should be noted that PD 98059 increased basal [ 3 H]AA levels by 30 -40% through an as yet unknown mechanism (Fig. 7) .
Inhibition of PI 3-kinase or MAPK activity does not modulate chronic AMPA receptor-evoked neurotoxicity in striatal neurons
Activation of MAPK may be important during oxidative and excitotoxic stimuli (Guyton et al., 1996; Murray et al., 1998; Samanta et al., 1998) , thus, we considered it possible that our (lanes 1-4 ) was analyzed using BioImage Intelligent Quantifier software. Each column is the mean Ϯ SEM value of five to six 4 independent cultures (n ϭ 5-6). *AM PA /C yz in the presence of PTX or wortmannin was significantly different from AM PA /C yz ( p Ͻ 0.05, unpaired two-tailed Student's t test) and **AM PA /C yz in the presence of LY 294002 was significantly different from AM PA /C yz ( p Ͻ 0.001, unpaired two-tailed Student's t test). observed AM PA receptor-evoked activation of M APK through PI 3-kinase could represent an early neurotoxic or survival signal that might be significant during AM PA /cyclothiazide-induced excitotoxicity. Application of AM PA (50 M) to striatal neurons for 4 hr produced no visible morphological effects [ (Fig. 8 Aii vs Ai (control)], and the capacity of striatal neurons to metabolize the tetrazolium salt MTT into formazan using mitochondrial succinate dehydrogenase, a marker for neuronal viability, was unaltered (Fig. 8 B) . However, in the presence of cyclothiazide (50 M; which alone had no deleterious effects), AMPA induced profound morphological changes to striatal neurons, including a loss of neurites and cell body integrity (Fig. 8 Aiii) . Furthermore, the ability of neurons to metabolize MTT into formazan was significantly reduced (Fig. 8 B) . Both of these effects were completely blocked by preincubation with the AMPA receptor antagonist GYKI 53655 (100 M) (Fig. 8 Aiv; data not shown), demonstrating that toxicity was mediated through cyclothiazidesensitive AMPA receptors as previously proposed (May and Robison, 1993; Cebers et al., 1997) . Chronic exposure (4 hr) of striatal neurons to either the MEK inhibitor PD 98059 (50 M) or the PI 3-kinase inhibitor wortmannin (100 nM) had no effect on neuronal morphology (data not shown) or MTT turnover (Fig.  8 B) and neither accelerated nor attenuated the neurotoxic actions of AMPA/cyclothiazide (Fig. 8 B) . These data suggest that these kinases do not play a role in neurotoxicity evoked by chronic AMPA receptor stimulation in striatal neurons.
AMPA receptors induce phosphorylation of the nuclear transcription factor CREB through a MAPK-dependent mechanism in striatal neurons
It has been reported that glutamate can induce phosphorylation and activation of the nuclear transcription factor CREB on the regulatory site Ser 133 in different brain regions Xia et al., 1996; Obrietan et al., 1998; Sgambato et al., 1998; Vanhoutte et al., 1999) , and it is thought that CREB activation may be an important step in processes underlying long-term memory (Frank and Greenberg, 1994; Deisseroth et al., 1996; Ginty, 1997) . Although NMDA-type glutamate receptors have been implicated in Ca 2ϩ -dependent activation of CREB Xia et al., 1996; Deisseroth et al., 1996) , it is not known whether CREB is also a downstream target for AMPA receptor-activated signaling pathways. We tested whether activation of Ca 2ϩ -permeable AMPA receptors leads to stimulation of CREB in cultured striatal neurons, using an antibody that detects CREB when it is phosphorylated on the regulatory site Ser 133 (anti-pCREB). Immunoblotting of neuronal homogenates, containing the nuclear fraction, and single cell immunocytochemistry with anti-pCREB showed that AMPA/cyclothiazide (50 M/50 M) induced a robust phosphorylation of CREB on Ser 133 in the nucleus of striatal neurons (Fig. 10 A, lane 2, Bii) . This effect was entirely dependent on the presence of extracellular Ca 2ϩ ( Fig.  10 A, lane 3) , was blocked by the AMPA receptor antagonist GYKI 53655 (100 M) (Fig. 10 Biii) , and was strongly inhibited by PD 98059 (50 M) and wortmannin (100 nM) (Fig. 10 A, lanes 4 and 5, respectively), indicating that stimulation of CREB by AMPA receptors is dependent on a PI 3-kinase-sensitive activation of the MAPK cascade.
DISCUSSION
There is some discrepancy in the literature with regard to the ability of AMPA receptors to activate the MAPK cascade. It has been reported that AMPA receptors can couple to the MAPK pathway in cortical neurons (Wang and Durkin, 1995) , whereas in hippocampal neurons AMPA and kainate do not appear to activate MAPK (Kurino et al., 1995) . In the latter study, a lack of AMPA effects could be caused by either rapid receptor desensitization or reduced Ca 2ϩ permeability resulting from the presence of Q/R-edited GluR2 subunits in the native receptor complexes: Ca 2ϩ influx through glutamate receptor channels is thought to be the trigger for MAPK activation (Xia et al., 1996) . Although it has been reported that AMPA and NMDA induce Figure 8 . Onset of Ca 2ϩ -permeable AM PA receptor-induced neurotoxicity is neither reversed nor accelerated by inhibition of M APK / PI 3-kinase activity. A, Striatal neurons were exposed to vehicle ( i), 50 M AMPA (ii), 50 M AMPA in the presence of 50 M cyclothiazide (Cyz) (iii), or 50 M AMPA and 50 M C yz in the presence of 100 M GYK I 53655 added 5 min before AM PA /C yz (iv) for 4 hr and then photographed under phase contrast microscopy (320ϫ magnification). B, Striatal neurons were exposed to vehicle or AM PA, with or without C yz (as described above), in the presence or absence of 50 M PD 98059 or 100 nM wortmannin (Wort) which were added 5 min before treatments. After 4 hr exposure, the culture medium was removed and MTT added as described in Materials and Methods. Results are expressed as the percent of formazan production relative to control, which was defined as 100%. Each column is the mean Ϯ SEM value of four independent cultures (n ϭ 4), each performed in triplicate. *AM PA /C yz was significantly different from AMPA ( p Ͻ 0.05, unpaired two-tailed Student's t test).
comparable increases in M APK activity in cultured striatal neurons (Vincent et al., 1998) , a direct C a 2ϩ -permeable AMPA receptor coupling to M APK cannot be concluded because of a lack of characterization of the AM PA response along with no antagonist data. Furthermore, this increase in MAPK activity with AMPA is somewhat surprising, as it has previously been shown that AMPA evokes either very weak or no functional responses in striatal neurons (Tence et al., 1995; Williams and Glowinski, 1996) unless rapid receptor desensitization is blocked with cyclothiazide (Petitet et al., 1995; Williams and Glowinski, 1996) . Similarly, in this study we show that AM PA alone does not significantly activate M APK . However, a robust AMPA receptor-evoked activation of ERK1 and ERK2 was unmasked with cyclothiazide. Intracellular C a 2ϩ measurements revealed that AM PA produced only a small rise in cytosolic C a 2ϩ , which may explain our observed lack of activation of M APK with AMPA alone. By contrast, in the presence of cyclothiazide, a large threefold increase in AM PA-evoked rises in cytosolic Ca 2ϩ was observed, and this enhanced response probably underlies the unmasking of AM PA receptor-evoked M APK stimulation. Further pharmacological characterization of AM PA /cyclothiazideevoked stimulation of ERK1/ ERK2 demonstrated that activation resulted from the direct influx of C a 2ϩ through the AMPA receptor itself with no secondary facilitatory involvement of either NMDA receptors or L -type voltage-sensitive Ca 2ϩ channels.
AM PA receptors appear to activate the M APK cascade in cortical neurons through a novel mechanism involving the ␤␥ subunits of P TX-sensitive G-proteins (Wang and Durkin, 1995) . Our finding that AM PA receptor-evoked activation of MAPK in striatal neurons was sensitive to P TX supports the concept that ionotropic receptors can transduce signals through G i /G o -type G-proteins (Wang et al., 1997; Rodriguez-Moreno and Lerma, 1998) . Recently, seven-transmembrane receptors coupled to inhibitory G-proteins have been shown to signal to MAPK in non-neuronal cells through a mechanism requiring the recruitment of PI 3-kinase (Hawes et al., 1996; L opez-I lasaca et al., 1997; Gutkind, 1998) . Interestingly, distinct from the well established phosphotyrosine-dependent activation of PI 3-kinase, rises in cytosolic C a 2ϩ can activate PI 3-kinase in chinese hamster ovary cells by inducing a direct association of calmodulin with both SH2 domains of the regulatory subunit (p85) of the kinase (Joyal et al., 1997) . We, therefore, considered that PI 3-kinase could be an important intermediate in our observed G i /G o -and Ca 2ϩ -dependent activation of M APK by AM PA receptors. Indeed, AM PA receptor activation of M APK was completely inhibited by the PI 3-kinase inhibitors wortmannin and LY 294002, indicating an essential role for PI 3-kinase in AM PA receptorstimulated ERK1 and ERK2 activation in striatal neurons. This is the first report of an involvement of PI 3-kinase in the regulation of postsynaptic AM PA receptor signaling in the C NS. MAPK activation was not modified by the PKC inhibitor Ro-31-8220, which is consistent with previous reports in non-neuronal cells that signaling to M APK via G␤␥ subunits and PI-3 kinase is independent of PKC (L uttrell et al., 1997) . Thus, although the specific protein -protein interactions that lead to activation of the Ras-M APK pathway by AM PA receptors are not currently known, it seems reasonable to propose that AM PA receptorevoked rises in cytosolic C a 2ϩ may trigger activation of PI 3-kinase and then recruitment of the lipid kinase to the MAPK cascade may, as is the case with seven-transmembrane G i /G o -type G-protein linked receptors, be orchestrated by free G␤␥ subunits. The specific exchange factors regulating Ras activity after AMPA receptor stimulation also remain to be determined. An involvement of the neuron-specific guanine nucleotide exchange factor, Ras-GRF, seems plausible because it has recently been demonstrated that Ras-GRF can be activated in response to increases in intracellular C a 2ϩ (Farnsworth et al., 1995; Finkbeiner and Greenberg, 1996) and /or free G-protein ␤␥ subunits that induce phosphorylation of Ras-GRF by as yet unknown kinases (Mattingly and Macara, 1996) .
However, Ca 2ϩ /calmodulin-dependent activation of Ras-GRF does not appear to involve PTKs (Farnsworth et al., 1995) , thus, our results indicating that tyrosine phosphorylation may be an important step in AMPA receptor activation of MAP kinase suggests that additional Ca 2ϩ -dependent routes to Ras may be activated. It has been proposed that PI 3-kinase can coordinate the activation of Src-like nonreceptor PTKs (Lopez-Ilasaca et al., 1997; Gutkind, 1998) . Furthermore, the Src and FAK families of PTKs have been strongly implicated in controlling Ca 2ϩ -dependent activation of the Ras/MAPK signaling pathway, however, it is not clear whether members of these two families act independently or together to coordinate association of the Grb2-Sos complex, which leads ultimately to the sequential activation of Ras, Raf kinase, and MEK (Lev et al., 1995; Finkbeiner and Greenberg, 1996) . We found that AMPA receptor-evoked activation of MAPK was completely blocked in the presence of the tyrosine kinase inhibitors genistein and PP2. It has recently been reported that PP2 selectively inhibits tyrosine kinases of the Src family, namely Src, Fyn, and Lck (all of which are present in the brain), while having negligible inhibitory activity against Jak2 or Zap PTKs (Hanke et al., 1996) . Our results with PP2 agree with previous work demonstrating that Src-like protein tyrosine kinases regulate Ca 2ϩ -dependent activation of the MAPK cascade (Rusanescu et al., 1995; Finkbeiner and Greenberg, 1996) and synaptic plasticity involving AMPA receptor activation (Boxall and Lancaster, 1998; Hayashi et al., 1999) . Whether or not PYK2, a member of the FAK family that has been shown to be important in Ca 2ϩ -dependent activation of the MAPK cascade (Lev et al., 1995) , is involved in neuronal AMPA receptor signaling remains to be determined.
CaM-KII is enriched at the postsynaptic density of glutamatergic synapses where one of its major roles is thought to be in the regulation of glutamate receptor responses (Fukunaga et al., 1992) . It has been shown that CaM-KII can phosphorylate AMPA receptor subunits (Mammen et al., 1997) , resulting in enhanced receptor currents (McGlade-McCulloh et al., 1993; Tan et al., 1994) , and this has been implicated in the strengthening of postsynaptic responses associated with synaptic plasticity (Barria et al., 1997) . We found that selective inhibition of CaM-KII activity with KN-62 substantially reduced AMPA/cyclothiazideevoked activation of MAPK without altering Ca 2ϩ influx through the receptor. These data indicate that CaM-KII can be a positive modulator of AMPA receptor signaling but that in the presence of cyclothiazide the kinase probably regulates AMPA receptormediated MAPK activation at a point downstream of Ca 2ϩ entry.
Our observation that ionomycin, which evokes a diffuse rise in bulk cytosolic Ca 2ϩ concentration, caused a significantly smaller activation of MAPK in comparison with that resulting from glutamate receptor stimulation, supports the hypothesis that MAPK requires high localized Ca 2ϩ rises for its activation in neurons Greenberg, 1996, 1997) . It seems likely therefore, that the initial Ca 2ϩ -sensing components of the MAPK cascade are in close proximity to the Ca 2ϩ -permeable AMPA receptors located at the plasma membrane.
One functional consequence of Ca 2ϩ -permeable AMPA receptor activation is a release of the signaling molecule AA from neurons (Williams and Glowinski, 1996) , which has been implicated in a range of physiological and pathological processes in the CNS (Piomelli, 1994) . A likely candidate for mobilizing AA is
